z-logo
Premium
BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTOLOGOUS STEM CELLS TRANSPLANTATION FOR HODGKIN LYMPHOMA: A REAL‐LIFE EXPERIENCE BY FONDAZIONE ITALIANA LINFOMI (FIL)
Author(s) -
Massaro F.,
Pavone V.,
Stefani P. M.,
Botto B.,
Pulsoni A.,
Patti C.,
Cantonetti M.,
Visentin A.,
Scalzulli P. R.,
Rossi A.,
Galimberti S.,
Cimminiello M.,
Gini G.,
Musso M.,
Sorio M.,
Arcari A.,
Zilioli V. R.,
Bari A.,
Mannina D.,
Fabbri A.,
Pietrantuono G.,
Annibali O.,
Tafuri A.,
Prete E.,
Mulè A.,
Barbolini E.,
Marcheselli L.,
Luminari S.,
Merli F.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.65_2881
Subject(s) - medicine , brentuximab vedotin , autologous stem cell transplantation , oncology , hematopoietic stem cell transplantation , population , transplantation , surgery , lymphoma , hodgkin lymphoma , environmental health

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom